Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tassilo Volz

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|January 9, 2014
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administrationLena Allweiss, Tassilo Volz, Marc Lütgehetmann, et al.
Scientific Reports|June 18, 2017
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized miceKatja Giersch, Maria Homs, Tassilo Volz, et al.
Journal of Hepatology|December 19, 2012
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusTassilo Volz, Lena Allweiss, Mounira Ben MBarek, et al.
Gut|April 22, 2017
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivoLena Allweiss, Tassilo Volz, Katja Giersch, et al.
Gut|January 29, 2021
Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivoLena Allweiss, Katja Giersch, Andrea Pirosu, et al.
The Journal of Clinical Investigation|May 1, 2019
T cell receptor grafting allows virological control of Hepatitis B virus infectionKarin Wisskirchen, Janine Kah, Antje Malo, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationMarc Lütgehetmann, Lida V Mancke, Tassilo Volz, et al.
Nature Biotechnology|February 26, 2008
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope proteinJoerg Petersen, Maura Dandri, Walter Mier, et al.
Gut|December 9, 2017
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivoKatja Giersch, Oliver D Bhadra, Tassilo Volz, et al.
Journal of Hepatology|November 28, 2013
Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infectionKatja Giersch, Martina Helbig, Tassilo Volz, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|January 9, 2014
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administrationLena Allweiss, Tassilo Volz, Marc Lütgehetmann, et al.
Scientific Reports|June 18, 2017
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized miceKatja Giersch, Maria Homs, Tassilo Volz, et al.
Journal of Hepatology|December 19, 2012
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusTassilo Volz, Lena Allweiss, Mounira Ben MBarek, et al.
Gut|April 22, 2017
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivoLena Allweiss, Tassilo Volz, Katja Giersch, et al.
Gut|January 29, 2021
Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivoLena Allweiss, Katja Giersch, Andrea Pirosu, et al.
The Journal of Clinical Investigation|May 1, 2019
T cell receptor grafting allows virological control of Hepatitis B virus infectionKarin Wisskirchen, Janine Kah, Antje Malo, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationMarc Lütgehetmann, Lida V Mancke, Tassilo Volz, et al.
Nature Biotechnology|February 26, 2008
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope proteinJoerg Petersen, Maura Dandri, Walter Mier, et al.
Gut|December 9, 2017
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivoKatja Giersch, Oliver D Bhadra, Tassilo Volz, et al.
Journal of Hepatology|November 28, 2013
Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infectionKatja Giersch, Martina Helbig, Tassilo Volz, et al.
Pageof 5